Navigation Links
Nanoparticle exposures happen, says expert
Date:10/11/2007

WASHINGTON, DC Some nanotechnology fanciers suggest that, like proverbial birds of a feather, engineered nanoscale materials will flock or clump together. This tendency, they maintain, should reduce or eliminate risks as nanotechnology manufacturing increases and the number of nanotechnology-enabled products grows.

Think again, cautions nanoparticle expert Andrew Maynard, chief science advisor to the Project on Emerging Nanotechnologies at the Woodrow Wilson International Center for Scholars, in a new article written for the United Kingdoms SAFENANO Initiative. Drawing on available scientific knowledge, Maynard disputes the claim that the so-called agglomeration of engineered nanomaterials will result in super-sized clusters so large that they cannot penetrate deep inside the body, thereby eliminating the potential for harm.

Will people really be exposed to engineered nanomaterials" Maynard writes. Despite protestations to the contrary, the science says, yes. There is certainly no reason to believe that exposures will not occur to both individual nanoparticles and agglomerates of nanoparticles that present a nano-specific risk. The article Is Engineered Nanomaterial Exposure a Myth" can be found at the SAFENANO website at: http://www.safenano.org/

Maynard points out that, in addition to addressing questions about exposure, resolving concerns about potential health risks of nanotechnology also will require better understanding of the toxicity of nanomaterials whether specific types of the materials are harmful or benign. The article is accompanied by the inaugural entry in Maynards new blog on the SAFENANO Initiative website at: http://community.safenano.org/Blogs/.

Both examine the current state of the science needed to answer questions about the potential environmental, health, and safety risks posed by nanotechnology so that the benefits can be maximized. Clearly, exposure to these materials will occur, Maynard explains in his blog entry. The challenge we face is surely to snap out of denial, and start to ask what the nature of the exposures will be, and whether they will lead to harm.


'/>"/>

Contact: Sharon McCarter
sharon.mccarter@wilsoncenter.org
202-691-4016
Project on Emerging Nanotechnologies
Source:Eurekalert

Related biology news :

1. DNA Molecules Used To Assemble Nanoparticles
2. Imaging Lymph Nodes with Nanoparticles
3. Taking Aim With Nanoparticle PEBBLEs
4. Probing The Promise And Perils Of Nanoparticles
5. Breakthrough method in nanoparticle synthesis paves the way for new pharmaceutical and biomedical applications
6. Probing the promise and perils of nanoparticles
7. Nanoparticles offer new hope for detection and treatment
8. Nanoparticle Breast Cancer Drug Approved by FDA
9. Novel gene-silencing nanoparticles shown to inhibit Ewings sarcoma
10. Using nanoparticles, in vivo gene therapy activates brain stem cells
11. Nanoparticles, nanoshells, nanotubes: How tiny specks may provide powerful tools against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... 2017 No two people are believed ... New York University Tandon School of Engineering and ... that partial similarities between prints are common enough ... phones and other electronic devices can be more ... lies in the fact that fingerprint-based authentication systems ...
(Date:4/5/2017)... , April 4, 2017 KEY FINDINGS ... anticipated to expand at a CAGR of 25.76% during ... diseases is the primary factor for the growth of ... report: https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global ... product, technology, application, and geography. The stem cell market ...
(Date:3/30/2017)... -- Trends, opportunities and forecast in this market to ... AFIS, iris recognition, facial recognition, hand geometry, vein recognition, ... industry (government and law enforcement, commercial and retail, health ... and by region ( North America , ... , and the Rest of the World) ...
Breaking Biology News(10 mins):
(Date:10/11/2017)... ... October 11, 2017 , ... The ... endogenous context, enabling overexpression experiments and avoiding the use of exogenous expression plasmids. ... is transformative for performing systematic gain-of-function studies. , This complement to loss-of-function ...
(Date:10/11/2017)... LAGUNA HILLS, Calif. , Oct. 11, 2017 /PRNewswire/ ... London (ICR) and University of ... tool to risk-stratify patients with multiple myeloma (MM), in a ... . The University of Leeds is ... Myeloma UK, and ICR will perform the testing services to ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... ... October 10, 2017 , ... USDM Life Sciences ... the life sciences and healthcare industries, announces a presentation by Subbu Viswanathan and ... presentation, “Automating GxP Validation for Agile Cloud Platforms,” will present a revolutionary approach ...
Breaking Biology Technology: